Cleared Traditional

K200275 - OVision Imaging System

K200275 is the FDA 510(k) clearance for OVision Imaging System by Ophthalmic Labs, Inc.. It is a Class 2 Ophthalmic device (product code NFJ) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K200275 · Ophthalmic Labs, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2020
Decision
28d
Days
Class 2
Risk

K200275 is an FDA 510(k) clearance for the OVision Imaging System. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Ophthalmic Labs, Inc. (Milton, US). The FDA issued a Cleared decision on March 3, 2020 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ophthalmic Labs, Inc. devices

Submission Details

510(k) Number K200275 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2020
Decision Date March 03, 2020
Days to Decision 28 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 110d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Consultant

Third Party Review Group, LLC
DAVE YUNGVIRT

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 33
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K200275.
ImageSPECTRUM
K201273 · Canon, Inc. · Sep 2020
Glaucoma Module
K200954 · Topcon Healthcare Solutions, Inc. · Aug 2020
CONTINUUM PACS
K200385 · Integrated Ophthalmic Systems, Inc. · Mar 2020
Huvitz Imaging System
K191615 · Huvitz Co., Ltd. · Jul 2019
KOWA VK-2s
K190056 · Kowa Co. Ltd. Chofu · Feb 2019
Afina
K181501 · Neurovision Imaging, LLC · Nov 2018